On Treatments and Tests Deferred: Preparing for Collateral Damage from COVID-19
Open Access
- 1 November 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 17 (11) , 1371-1373
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort StudyGastroenterology, 2020
- Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in ItalyNew England Journal of Medicine, 2020
- Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern ItalyNew England Journal of Medicine, 2020
- The Untold Toll — The Pandemic’s Effects on Patients without Covid-19New England Journal of Medicine, 2020
- Virtually Perfect? Telemedicine for Covid-19New England Journal of Medicine, 2020
- Covid-19: Cancer mortality could rise at least 20% because of pandemic, study findsBMJ, 2020
- Safety, feasibility, and effectiveness of virtual pulmonary rehabilitation in the real worldInternational Journal of Chronic Obstructive Pulmonary Disease, 2019
- Public health impact of the 2014–2015 Ebola outbreak in West Africa: seizing opportunities for the futureBMJ Global Health, 2017
- Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2016